...
首页> 外文期刊>BMC Genomics >Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations
【24h】

Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations

机译:分子对接模拟中结核分枝杆菌InhA酶显性柔性的影响

获取原文
           

摘要

BackgroundProtein/receptor explicit flexibility has recently become an important feature of molecular docking simulations. Taking the flexibility into account brings the docking simulation closer to the receptors’ real behaviour in its natural environment. Several approaches have been developed to address this problem. Among them, modelling the full flexibility as an ensemble of snapshots derived from a molecular dynamics simulation (MD) of the receptor has proved very promising. Despite its potential, however, only a few studies have employed this method to probe its effect in molecular docking simulations. We hereby use ensembles of snapshots obtained from three different MD simulations of the InhA enzyme from M. tuberculosis (Mtb), the wild-type (InhA_wt), InhA_I16T, and InhA_I21V mutants to model their explicit flexibility, and to systematically explore their effect in docking simulations with three different InhA inhibitors, namely, ethionamide (ETH), triclosan (TCL), and pentacyano(isoniazid)ferrate(II) (PIF).ResultsThe use of fully-flexible receptor (FFR) models of InhA_wt, InhA_I16T, and InhA_I21V mutants in docking simulation with the inhibitors ETH, TCL, and PIF revealed significant differences in the way they interact as compared to the rigid, InhA crystal structure (PDB ID: 1ENY). In the latter, only up to five receptor residues interact with the three different ligands. Conversely, in the FFR models this number grows up to an astonishing 80 different residues. The comparison between the rigid crystal structure and the FFR models showed that the inclusion of explicit flexibility, despite the limitations of the FFR models employed in this study, accounts in a substantial manner to the induced fit expected when a protein/receptor and ligand approach each other to interact in the most favourable manner.ConclusionsProtein/receptor explicit flexibility, or FFR models, represented as an ensemble of MD simulation snapshots, can lead to a more realistic representation of the induced fit effect expected in the encounter and proper docking of receptors to ligands. The FFR models of InhA explicitly characterizes the overall movements of the amino acid residues in helices, strands, loops, and turns, allowing the ligand to properly accommodate itself in the receptor’s binding site. Utilization of the intrinsic flexibility of Mtb’s InhA enzyme and its mutants in virtual screening via molecular docking simulation may provide a novel platform to guide the rational or dynamical-structure-based drug design of novel inhibitors for Mtb’s InhA. We have produced a short video sequence of each ligand (ETH, TCL and PIF) docked to the FFR models of InhA_wt. These videos are available at http://www.inf.pucrs.br/~osmarns/LABIO/Videos_Cohen_et_al_19_07_2011.htm.
机译:背景技术蛋白质/受体的显式柔性最近已成为分子对接模拟的重要特征。考虑到灵活性,对接模拟使其更接近受体在自然环境中的真实行为。已经开发出几种方法来解决这个问题。其中,将完整的灵活性建模为从受体的分子动力学模拟(MD)导出的快照集合非常有希望。尽管有其潜力,但是,只有很少的研究采用这种方法来探究其在分子对接模拟中的作用。我们在此使用从结核分枝杆菌(Mtb),野生型(InhA_wt),InhA_I16T和InhA_I21V突变体的InhA酶的三种不同MD模拟获得的快照合集来模拟它们的显性灵活性,并系统地探索它们的作用与三种不同的InhA抑制剂对接模拟,即乙硫酰胺(ETH),三氯生(TCL)和戊酸高铁(异烟肼)II(PIF)。结果使用了InhA_wt,InhA_I16T和InhA_wt的全柔性受体(FFR)模型InhA_I21V突变体与抑制剂ETH,TCL和PIF的对接模拟显示,与刚性InhA晶体结构(PDB ID:1ENY)相比,它们的相互作用方式存在显着差异。在后者中,最多只有五个受体残基与三个不同的配体相互作用。相反,在FFR模型中,这个数字增长到惊人的80个残基。刚性晶体结构与FFR模型之间的比较表明,尽管本研究中使用的FFR模型存在局限性,但包含明显的柔韧性在很大程度上解释了蛋白质/受体和配体接近时预期的诱导拟合结论蛋白/受体的显性灵活性或FFR模型(表示为MD模拟快照的集合)可以导致更实际地表示预期的感应契合效果,并与受体正确对接。配体。 InhA的FFR模型清楚地描述了螺旋,链,环和匝中氨基酸残基的整体运动,从而使配体正确地容纳在受体的结合位点中。通过分子对接模拟在虚拟筛选中利用Mtb的InhA酶及其突变体的内在灵活性,可以提供一个新颖的平台,指导基于合理或动态结构的Mtb的InhA抑制剂抑制剂的药物设计。我们制作了与InhA_wt的FFR模型对接的每个配体(ETH,TCL和PIF)的简短视频序列。这些视频可从http://www.inf.pucrs.br/~osmarns/LABIO/Videos_Cohen_et_al_19_07_2011.htm获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号